DGXQuest Diagnostics
$255.60+47% 1Y
$255.60
$171.9552 weeks$255.60
Latest close: a new 52-week highNov 6, 2026what changed →
Operating metrics
Requisition volume growth at Quest Diagnostics: 14.5% for Q3 2026, +2.0 points on a year ago.
Operating metrics
From earnings releases, Q3 2021 to Q3 2026
Requisition volume growth, Q3 2026+2.0 points on a year ago14.5%
+2.0 points on a year ago
Revenue per requisition growth−4.2%
Q3 2026, −5.0 points on a year ago
Requisition volume growth, Q3 2026: 14.5%
Requisition volume14.5%12.9%
Source: Q3 2026 earnings release, filed Oct 22, 2026Every quarter, with its source
| Quarter | Requisition volume growth | Revenue per requisition growth | Release |
|---|---|---|---|
| Q3 2026 | 14.5% | −4.2% | Filed Oct 22, 2026 |
| Q2 2026 | 13.1% | −2.8% | Filed Jul 23, 2026 |
| Q1 2026 | 10.9% | −1.3% | Filed Apr 21, 2026 |
| Q4 2025 | 8.5% | −0.1% | Filed Feb 10, 2026 |
| Q3 2025 | 12.5% | 0.8% | Filed Oct 21, 2025 |
| Q2 2025 | 16.3% | −0.4% | Filed Jul 22, 2025 |
| Q1 2025 | 12.4% | 0.3% | Filed Apr 22, 2025 |
| Q4 2024 | 13.9% | 0.2% | Filed Jan 30, 2025 |
| Q3 2024 | 5.5% | 3.3% | Filed Oct 22, 2024 |
| Q2 2024 | 1.1% | 1.6% | Filed Jul 23, 2024 |
| Q1 2024 | 1.6% | 0.1% | Filed Apr 23, 2024 |
| Q4 2023 | 1.9% | −3.5% | Filed Feb 1, 2024 |
| Q3 2023 | −0.5% | −7.2% | Filed Oct 24, 2023 |
| Q2 2023 | 0.2% | −4.9% | Filed Jul 26, 2023 |
| Q1 2023 | −3.8% | −7.7% | Filed Apr 27, 2023 |
| Q4 2022 | −11.2% | −5.1% | Filed Feb 2, 2023 |
| Q3 2022 | −6.2% | −5.1% | Filed Oct 20, 2022 |
| Q2 2022 | −1.4% | −2.6% | Filed Jul 21, 2022 |
| Q1 2022 | 1.3% | −5.2% | Filed Apr 21, 2022 |
| Q4 2021 | 1.3% | −9.8% | Filed Feb 3, 2022 |
| Q3 2021 | 5.3% | −5.4% | Filed Oct 21, 2021 |
- Requisition volume growth
- Year-over-year change in the number of requisitions (patient test orders) in Diagnostic Information Services for the quarter.
- Revenue per requisition growth
- Year-over-year change in average revenue per requisition in Diagnostic Information Services for the quarter.
Source: company earnings releases furnished to the SEC on Form 8-K (Item 2.02, Exhibit 99), SEC EDGAR.
Diagnostics & Research
The closest names by size in the same industry